Treatment of clinical Brachyspira hyodysenteriae with zinc chelate in pigs: a blinded, randomised controlled trial

Gerwen Lammers,Robbert van Berkel,Daisy Roijackers,Carly Vulders,Henriëtte Brouwer-Middelesch,Jobke van Hout
DOI: https://doi.org/10.1136/vr.105523
IF: 2.56
2019-11-01
Veterinary Record
Abstract:BACKGROUND: Brachyspira hyodysenteriae infection in pigs ('swine dysentery') leads to decreased feed conversion, growth losses and mortality. Current countermeasures have the downside of antibiotic resistance (antibiotics) and ecotoxicity (zinc oxide). The aim of this study was to evaluate the effect of a novel zinc chelate (Intra Dysovinol (ID)) on clinical signs of swine dysentery and shedding of B hyodysenteriae under field conditions.METHODS: In a randomised, double-blinded, controlled trial under Good Clinical Practice on two commercial farms, 58 B hyodysenteriae positive pigs from 16 pens received drinking water containing ID, or placebo, during six consecutive days. Faecal quality (consistency, colour, additions) was scored and faeces were analysed for presence of B hyodysenteriae by PCR. ID treatment positively affected faecal quality (consistency) and daily growth rates.RESULTS: At the last treatment day, B hyodysenteriae was not detectable in the faeces of any of the ID-treated animals, while all placebo animals remained B hyodysenteriae positive by PCR. All ID-treated animals recovered, while 5 placebo-treated animals died and 12 placebo pigs required additional treatment before the end of the study (up to 14 days after treatment start).CONCLUSION: This non-antibiotic treatment stopped the clinical signs and shedding of B hyodysenteriae in naturally infected pigs.
veterinary sciences
What problem does this paper attempt to address?